Multiple sclerosis may lead to mild ... and numbness. However, if lesions develop on parts of the brain that process memories, it can lead to memory loss. Some research suggests that over 6 ...

Let's talk about how multiple sclerosis impacts cognitive function ... So what we know is that from a neurologic standpoint, lesions in the brain and atrophy of the brain, which occurs in both ...

Multiple sclerosis, or MS, is a chronic neurological disease that impacts the brain, spinal cord, and central nervous system. Your brain uses electrical signals to communicate with your body.

A new study investigated the brain circuits involved in psychosis—a condition characterized by delusions, hallucinations, ...

More information: Jack A. Reeves et al, Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis, Annals of Clinical and Translational Neurology (2024). DOI ...

Currently, patients with clinically isolated syndrome (CIS) and brain lesions on MRI suggestive of multiple sclerosis (MS), are offered a confirmatory MRI scan after 6 months. Researchers in Italy ...

Multiple sclerosis (MS) symptoms worsen if you become ... to MS. It interferes with the transmission of nerve signals to the brain. Symptoms include blurry or reduced vision.

The name multiple sclerosis refers to scars (scleroses—better known as plaques or lesions) particularly in the white matter of the brain and spinal cord, which is mainly composed of myelin.

The following is a summary of “Conventional MRI-Based Structural Disconnection and Morphometric Similarity Networks and Their ...

More information: Aletta M. R. van den Bosch et al, Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation, Nature Communications (2024). DOI: 10.1038/s41467 ...

Positive brain MRI (9 T2 lesions or ≥ 4 T2 lesions with positive ... Positive CSF Table used with permission: National Multiple Sclerosis Society Research Bulletins. International panel updates ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...